ATR and cancer: To further explore how inhibition of ATR impacts the Top2 complexes and selectively sensitizes p53-deficient cancer cells to etoposide, we used a clonogenic assay to evaluate the ability of cells to survive different etoposide concentrations in the presence or absence of the ATR inhibitor AZ-20.